|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9200 AUD | +1.10% |
|
-2.37% | -14.52% |
| 02/02 | Orthocell Eyes Fiscal 2027 Entry Into UK, European Union Markets | MT |
| 19/01 | Orthocell posts quarterly revenue of A$3.2 million | RE |
Evolution of the Average Target: Orthocell Limited
Evolution of the Target Price: Orthocell Limited
Changes in Analyst Recommendations: Orthocell Limited
2524642a0.6PmyNsvxLoUjdhKzMtdO3n3lZVeTmBtamEiWdgk-0-E.o5veeYqoYvBSMSrJfKB25j-PUBzB1ldp8CXyOGQTuZmJydAFgIQZykFAeQ~6a43b22f48a2d2f9e22ec4befb3aff27
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| - | - | - | - | +46.15% | ||
| +22.77% | ||||||
| +25.33% | ||||||
| +22.28% | ||||||
| +40% | ||||||
| +34.26% | ||||||
| +23.37% | ||||||
| +9.51% | ||||||
| +15.62% | ||||||
| +30.94% | ||||||
| Average | +27.03% | |||||
| Weighted average by Cap. | +25.68% |
Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9100AUD
Average target price
1.330AUD
Spread / Average Target
+46.15%
High Price Target
1.330AUD
Spread / Highest target
+46.15%
Low Price Target
1.330AUD
Spread / Lowest Target
+46.15%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Canaccord Genuity |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9100AUD
Average target price
1.330AUD
Spread / Average Target
+46.15%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OCC Stock
- Consensus Orthocell Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















